Showing results (111-120 of 119) with videos related to
Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 27, 2018
Recommendations for extracorporeal cardiopulmonary resuscitation (eCPR): consensus statement of DGIIN, DGK, DGTHG, DGfK, DGNI, DGAI, DIVI and GRCGuido Michels, Tobias Wengenmayer, Christian Hagl, et al.Clinical Chemistry|March 24, 2018
Quality Control of Serum and Plasma by Quantification of (4E,14Z)-Sphingadienine-C18-1-Phosphate Uncovers Common Preanalytical Errors During Handling of Whole BloodXinyu Liu, Miriam Hoene, Peiyuan Yin, et al.JAMA|June 14, 2012
Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trialFrank M Brunkhorst, Michael Oppert, Gernot Marx, et al.Intensive Care Medicine|May 4, 2017
Effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality: a cluster randomized trialFrank Bloos, Hendrik Rüddel, Daniel Thomas-Rüddel, et al.Nature Communications|October 4, 2017
NFAT2 is a critical regulator of the anergic phenotype in chronic lymphocytic leukaemiaMelanie Märklin, Jonas S Heitmann, Alexander R Fuchs, et al.German Medical Science : GMS E-Journal|July 10, 2023
Quality indicators in intensive care medicine for Germany - fourth edition 2022Oliver Kumpf, Markus Assenheimer, Frank Bloos, et al.Medizinische Klinik, Intensivmedizin Und Notfallmedizin|April 16, 2024
[Clinical acute and emergency medicine curriculum-focus on internal medicine : Recommendations for advanced training in internal medicine in the emergency department], , , et al.Medizinische Klinik, Intensivmedizin Und Notfallmedizin|December 16, 2025
[Core curriculum of intensive care and emergency medicine in internal medicine], , , et al.Intensive Care Medicine|April 11, 2018
Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)Tobias Welte, R Phillip Dellinger, Henning Ebelt, et al.Pageof 12